• OPEN AN ACCOUNT
Indian Indices
Nifty
26,053.90 117.70
(0.45%)
Sensex
84,997.13 368.97
( 0.44%)
Bank Nifty
58,385.25 171.15
( 0.29%)
Nifty IT
36,090.10 229.70
( 0.64%)
Global Indices
Nasdaq
47,736.03 170.44
(0.36%)
Dow Jones
6,915.96 19.80
(0.29%)
Hang Seng
51,290.81 1,071.63
(2.13%)
Nikkei 225
9,704.22 50.40
(0.52%)
Forex
USD-INR
88.12 0.31
(0.36%)
EUR-INR
102.54 0.45
(0.44%)
GBP-INR
117.47 0.63
(0.54%)
JPY-INR
0.58 0.00
(0.35%)

EQUITY - MARKET SCREENER

Sanofi India Ltd
Industry :  Pharmaceuticals - Multinational
BSE Code
ISIN Demat
Book Value()
500674
INE058A01010
339.6135475
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SANOFI
30.66
10930.73
EPS(TTM)
Face Value()
Div & Yield %
154.81
10
2.46
 

sanofi india ltd
Board of Sanofi India approves change in directorate
Oct 27,2025
The Board of Sanofi India at its meeting held on 27 October 2025 has approved the following-

Appointment of Deepak Arora (DIN: 07495638) as an Additional Director of the Company with effect from 27 October 2025 and as a Managing Director (Key Managerial Personnel) of the Company for a term of 3 (three) years effective from 27 October 2025.

Stepping down of Rachid Ayari as Interim Managing Director of the Company with effect from close of 26 October 2025. However, Rachid Ayari would continue to serve the Company in his role as Whole time Director and Chief Financial Officer of the Company.